Get started
Author

András Seres

Observed names: A SERES, A. Seres, A. Serés, Andras I. Seres, Andras Seres, Andra´s Seres, Andràs Seres, András I. Seres, Seres András
ORCID: 0000-0001-8260-3566
Observed ORCID: 0000-0001-8260-3566
OpenAlex ID: A5001673908
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials
2022 · Jeffrey S Heier, Arshad M Khanani, et al. · The Lancet · 815
PDF
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials
2022 · Charles C Wykoff, Francis Abreu, et al. · The Lancet · 534
PDF
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial
2023 · Arshad M Khanani, Sunil S Patel, et al. · The Lancet · 392
PDF
TENAYA and LUCERNE
2024 · Arshad M. Khanani, Aachal Kotecha, et al. · Ophthalmology · 251
Faricimab Treat-and-Extend for Diabetic Macular Edema
2023 · Tien Y. Wong, Zdenka Haskova, et al. · Ophthalmology · 192
PDF
Intravitreal Aflibercept for Macular Edema Secondary to Central Retinal Vein Occlusion: 18-Month Results of the Phase 3 GALILEO Study
2014 · Yuichiro Ogura, Johann Roider, et al. · American Journal of Ophthalmology · 162
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial
2024 · David M Brown, David S Boyer, et al. · The Lancet · 153
PDF
Expert Opinion on Management of Intraocular Inflammation, Retinal Vasculitis, and Vascular Occlusion after Brolucizumab Treatment
2020 · Caroline R. Baumal, Bahram Bodaghi, et al. · Ophthalmology Retina · 153
PDF
Efficacy and Safety of Faricimab for Macular Edema due to Retinal Vein Occlusion
2024 · Ramin Tadayoni, Liliana P. Paris, et al. · Ophthalmology · 97
PDF
The SECURE Study
2012 · Rufino Silva, Ruth Axer-Siegel, et al. · Ophthalmology · 89
PDF
Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study
2006 · Maria L. Ribeiro, Andras I. Seres, et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 74
Clinical Characteristics and Outcomes of Eyes with Intraocular Inflammation after Brolucizumab: Post Hoc Analysis of HAWK and HARRIER
2021 · Michael Singer, Thomas A. Albini, et al. · Ophthalmology Retina · 70
PDF
BALATON and COMINO: Phase III Randomized Clinical Trials of Faricimab for Retinal Vein Occlusion
2023 · Lars-Olof Hattenbach, Francis Abreu, et al. · Ophthalmology Science · 38
Vision-Related Quality of Life in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept
2019 · Justus G. Garweg, Jana Stefanickova, et al. · Ophthalmology Retina · 35
PDF
Intravitreal Aflibercept 8 mg for Diabetic Macular Edema
2025 · Diana V. Do, Charles C. Wykoff, et al. · Ophthalmology · 27
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial
2023 · Masahiko Shimura, Shigehiko Kitano, et al. · Japanese Journal of Ophthalmology · 23
PDF
Vogt–Koyanagi–Harada disease presenting initially as aseptic meningoencephalitis
2000 · A. Kamondi, A. Szegedi, et al. · European Journal of Neurology · 23
Aflibercept Biosimilar MYL-1701P vs Reference Aflibercept in Diabetic Macular Edema
2024 · Susan B. Bressler, Abhijit Barve, et al. · JAMA Ophthalmology · 21
PDF
Photodynamic (verteporfin) therapy for retinal capillary haemangioma, with monitoring of feeder and draining blood vessel diameters
2005 · Antal Szabó, Zsuzsanna Géhl, et al. · Acta Ophthalmologica Scandinavica · 20
PDF
The Diameters of the Human Retinal Branch Vessels Do Not Change in Darkness
2003 · Gyo¨rgy Barcsay, Andra´s Seres, et al. · Investigative Ophthalmology & Visual Science · 20
Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial
2022 · Justus G. Garweg, Jana Štefanickova, et al. · Advances in Therapy · 19
PDF
Presentation delay in patients affected with exudative age-related macular degeneration
2001 · Walid M. Haddad, Andras Seres, et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 12
Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy
2025 · Won Ki Lee, Tien Y. Wong, et al. · JAMA Ophthalmology · 10
Central Corneal Thickness Measurements with Optical Coherence Tomography and Ultrasound Pachymetry in Healthy Subjects and in Patients after Photorefractive Keratectomy
2009 · Miklos Schneider, Gabor Borgulya, et al. · European Journal of Ophthalmology · 9
Suggested Terminology for Different Phases of Indocyanine Green Angiogram
2000 · Gisèle Soubrane, Andràs Seres, et al. · Retina · 4
Works count: 42
Citation count: 3,449
H-index: 20
I10-index: 24
Year
Topic
Type